JO
CALC icon

John Overdeck’s CalciMedica CALC Stock Holding History

John Overdeck’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,230
Closed -$19K – 2494
2022
Q2 		$19K Sell
1,230
-2,417
-66% -$33K ﹤0.01% 2410
2022
Q1 		$63K Sell
3,647
-3,022
-45% -$57.6K ﹤0.01% 2476
2021
Q4 		$171K Buy
+6,669
New +$259K ﹤0.01% 3965
2021
Q2 		– Sell
-5,351
Closed -$416K – 4073
2021
Q1 		$416K Buy
+5,351
New +$1.6M ﹤0.01% 3093

Other funds holding CALC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's CALC Position: Q3 2022 in Review

John Overdeck sold out of CalciMedica (CALC) in Q3 2022, closing a stake of 1,230 shares — an estimated $19K sold.

John Overdeck first reported a position in CALC in Q1 2021 and held it in 4 quarters. The position peaked at $416K in Q1 2021. 25 funds tracked by Wall St. Rank hold CALC as of Q3 2022.

  • John Overdeck reported no remaining CalciMedica position as of Q3 2022 after selling out during the quarter.
  • John Overdeck sold 1,230 CalciMedica shares in Q3 2022, an estimated $19K.
  • John Overdeck first reported a position in CalciMedica in Q1 2021 and held it in 4 quarters.
  • John Overdeck's CalciMedica position peaked at $416K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held CalciMedica as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.